Latest News In Energy Transition - Transformers Market Growth Driven By Grid Modernization And Innovation
Tesla Motors, Inc. TSLA | 0.00 |
The global transformers market is poised for significant growth, anticipated to reach USD 113.0 billion by 2036, up from USD 62.2 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.2%. This expansion is fueled by key developments in grid modernization, renewable energy advancements, and the burgeoning demand for electric vehicle charging infrastructure. With Asia-Pacific currently leading the market due to extensive industrialization, regions like North America are expected to follow closely, with investments in advanced grid substations. The emphasis on integrating advanced power equipment, high-speed signal demands, and the expansion of 5G-enabled smart grid infrastructure are pivotal in creating new opportunities within this transformative energy landscape.
In other market news, Wharf (Holdings) (SEHK:4) was a notable mover up 14.2% and ending the day at HK$29.90. At the same time, Primoris Services (NYSE:PRIM) softened, down 50.1% to end the day at $101.23. Two days ago, the company reported a significant decline in quarterly earnings, with net income dropping from USD 44.2 million to USD 17.4 million.
Best Energy Transition Stocks
- Tesla (NasdaqGS:TSLA) finished trading at $398.73 up 2.4%.
- GE Vernova (NYSE:GEV) settled at $1,118.96 up 2.2%. Blue Energy and the company announced a 2.5 GW gas-plus-nuclear collaboration three days ago, combining innovative financing with the company's reactor technology.
- Equinor (OB:EQNR) closed at NOK349.90 down 8.7%. On Wednesday, the company reported decreased sales and revenue year-on-year for Q1 2026, but increased net income and earnings per share.
Where To Now?
- Click through to start exploring the rest of the 189 Energy Transition Stocks including Guangxi Guiguan Electric PowerCo.Ltd, Jinko Solar and Duke Energy now.
- Looking For Alternative Opportunities? AI is about to change healthcare. These 121 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Sources:
